Trade Now

Capital at risk Advertisement
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 30.50 44,849 08:00:00
Bid Price Offer Price High Price Low Price Open Price
30.00 31.00 30.50 30.50 30.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 2.21 6.18 7.15 4.3 27
Last Trade Time Trade Type Trade Size Trade Price Currency
16:26:40 O 16,758 29.885 GBX

Optibiotix Health (OPTI) Latest News

More Optibiotix Health News
Optibiotix Health Investors    Optibiotix Health Takeover Rumours

Optibiotix Health (OPTI) Discussions and Chat

Optibiotix Health Forums and Chat

Date Time Title Posts
15/8/202218:00OptiBiotix Health PLC - 17,314
15/8/202209:09OptiBiotix - The uncensored thread 60,895
20/7/202217:06OptiBiotix - Better Science, Better Health. Better buy some!58,105
11/2/202215:16OptiBiotix Health (Facts NOT Fiction)5,379
01/2/202121:24SentimentalRules AKA idoflykathy77

Add a New Thread

Optibiotix Health (OPTI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
15:26:4229.8916,7585,008.13O
15:26:1129.9216,7415,008.14O
11:55:3230.562,781849.87O
10:18:1830.101,000301.00O
09:17:5330.122,725820.82O
View all Optibiotix Health trades in real-time

Optibiotix Health (OPTI) Top Chat Posts

DateSubject
15/8/2022
09:20
Optibiotix Health Daily Update: Optibiotix Health Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 30.50p.
Optibiotix Health Plc has a 4 week average price of 30p and a 12 week average price of 20.50p.
The 1 year high share price is 57.50p while the 1 year low share price is currently 20.50p.
There are currently 88,065,661 shares in issue and the average daily traded volume is 93,494 shares. The market capitalisation of Optibiotix Health Plc is £26,860,026.61.
22/7/2022
21:15
vlad the impaler: ANd as SR says "There is only one thing worse for them than I losing money on OPTI, and that is making money" haha I guess it is why he has no issue supporting the share price - "business is business. Personal is for the street ring" Whatever that means
15/7/2022
18:38
m4rtinu: Vaston - slightly dated to say the least, that link. We need to get a life (ok, me included), as I'm joining in. No doubt global shocks are a worry. And Opti not immune. But great recovery in share price in last 2 weeks. Big Q, why was it? What will support share price at this level? Let's hope some further collaboration /deals on Sweet. In the meantime, a bit of perspective. This is just a game. Albeit, possibly costly (or not!) for some. Have a watch of F Flintoff's doc on BBC. Trying to get some rascals and unloved kids to improve their lives through cricket. A really worthwhile project. And while we are at it. Hope for cessation of War in Ukraine. Love to all. MU.
14/7/2022
19:55
vlad the impaler: I don't get it Tom..are your warrants pressuring you to now believe everything and quote the greatness? 😂😂😂 400% upside in Optibiotix shares - new Cenkos note Cenkos is house broker to Optibiotix (OPTI) so it is biased. I own shed loads of shares so am biased. The forecasts in the note out today include sod all for the three major deals announced at Christmas. So they will be increased. Read into this what you want. My pension will be buying more shares at around the current level if it can
14/7/2022
17:31
vlad the impaler: Lemming Investors OptiBiotix - Partners and Products 2017-2019 OptiBiotix Health (OPTI) management have often spoken about commercial traction building in H2 2018, and break-even YE 2018. We are told break-even turned out to be almost three months early, most of the commercial traction is coming from the ProBiotix technology platform. There is the expectation for an acceleration in commercial traction in 2019, thereafter, exponential growth in 2020 as more of the much larger agreements with multinational partner begin to come on stream, all of which falls to the bottom-line. We have seen new product launches with Galenicum, Olliscience, and Muscle Form, and Aragan, being the latest find and yet OPTI did not see fit to notify the market, or at least this is the allegation from some quarters. With the exception of Galenicum, where OPTI did notify the market, we will see a growing number of new product launches before the year is out and into 2019 as OPTI distributors sell SlimBiome and LP-LDL products to their clients. These partners will absorb 100% of the sales and marketing spend, not OPTI. The beauty of this is the fact revenues will be building in the background without the wider market realising until it is too late...the patient and the savvy investor will be aware of course. On Tuesday 19th March Stephen O'Hara confirmed the "majority of partners are generating revenues." The company is already profitable, and more and more of the larger deals signed-off 9 months ago will soon be adding to a rapidly upward revenue trend, which will certainly accelerate into 2020, and yet there even larger deals pregnant. The question is, how many more are out there or about to launch? What we witnessing is the green shoots of the business model developing under the radar. I'm hoping for a clear sign the hockey stick effect is well ahead of the curve and we get a positive forward-looking statement and promptly reported FY or worse is to come. In the meantime, I would like to remind investors of the value adding and growing product pipeline that is building momentum, with science-backed and award-winning products.
10/7/2022
18:35
vlad the impaler: OPTI has been easy pickings for buy side sellers and shorters for a few years at common averages. But share price has dropped hard away from those so, same again Sam? Seems a specialist in speculative rises and actual news drops [...] — Hades Shack (@HadesShack) July 10, 2022
01/7/2022
12:14
pol pot: As part of the OptiBiotix Share Option Plan, options over 500,000 new ordinary shares have been granted to René Kamminga (the "Options"). The Options are exercisable within 10 years at an exercise price of 2p per share, which will be subject to a combination of performance and time-based vesting criteria.
01/5/2022
21:11
kreature: "How can you expect Opti share price to do well when it just got asset stripped?" More like asset-gang-raped when you consider the price paid ?
01/5/2022
18:24
vlad the impaler: In basic essence, the CLN was a transfer of ownership PBX could only go to IPO with something sellable in a brochure be it assets, cash or both . Plus whatever customers and so on. Patents ? Trademarks! I don't know the list Where all that come from? Basically CLN holders took value from opti to flog to another bunch of gerbils elsewhere How can you expect Opti share price to do well when it just got asset stripped? And market, looking at sbtx etc, have little to no faith in opti returns for real cash lol. IE market does not think the cash from sbtx will be of any value to them . That's the history so I'm sure they expect same of opti and PBX stock Was a great get rich quick scheme. And give the gerbils a few porridge tokens (call it div reward lol) to shut them up 😂 De-Risk.....a fair few Aim companies coming out with that one now. Must be the new trend
07/4/2022
19:25
vlad the impaler: The CEO says the spin outs are about de-risking shareholders. He is the largest holder at around 11% or so right? ['''OptiBiotix plc has subscribed for £250,000 of CLNs. Steve O'Hara, a director of the Company, has subscribed for £25,000 and certain close family members of Mr. O'Hara have subscribed for £265,000. In addition, Per Rehné, a director of the Company, has subscribed for £25,000. The remaining subscribers include two institutional investors and two industry partners....] Ok so, it seems between the free shares on his opti 11%, plus the £290,000 of CEO and family..... seems so de-risked ---- it is now -100% risk? Seems to be the biggest benefactor of the IPO in about 10 ways So, hmmm, if it was me, the asset transfer by opti would have now become 50 million lol Just to crunch numbers, what is the IPO plus free stock on opti holdings estimated to be worth? Did he mean de-risk or 'retire nicely' Either way, CEO and family will be by far , richer than opti for it all I hope opti pays a massive bonus for the spinout too.
01/4/2022
17:06
vlad the impaler: OPTI is being bled/stripped for the next IPO OPTI shareholders been paying 3% yield to CLN holders for years too OPTI has delivered nothing only spin off cash cows and terrible financials You speak of div paying holders yet you cant give a figure, and it could be little to nothing once able to realise it. You also fail to note, those who can only assuredly make on the IPO, in essence,....already have You also fail to note that the average price paid for OPTI stock by volume/transaction, is above 84p That Sir, means nothing is paying, no matter what spin you put on it ..................... SOme say, look at sbtx... sure, what a show lol. But here they say a spin off is to de-risk opti holders Just to define that, it means spinning out risk to take risk from opti holders, but can reward opti holders .............. It has not happened
Optibiotix Health share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
OPTI
Optibiotix..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220815 21:44:03